Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Neuroendocrine tumor of the uterine cervix: a clinicopathologic study of 14 cases.

Peng P, Ming W, Jiaxin Y, Keng S.

Arch Gynecol Obstet. 2012 Nov;286(5):1247-53. doi: 10.1007/s00404-012-2407-2. Epub 2012 Jun 14.

PMID:
22695823
2.

[Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].

Wang Z, Wu L, Yao H, Sun Y, Li X, Li B, Zhang R, Ma S, Huang M.

Zhonghua Fu Chan Ke Za Zhi. 2015 Mar;50(3):198-203. Chinese.

PMID:
26268410
3.

[Clinical analysis of the recurrence of early stage bulky cervical carcinoma].

Hu JL, Wu LY, Li XG, Zhang R, Li N, Yao HW.

Zhonghua Zhong Liu Za Zhi. 2012 May;34(5):378-81. doi: 10. 3760/cma.j.issn.0253-3766.2012.05.014. Chinese.

PMID:
22883461
4.

[Clinicopathologic analysis of small cell neuroendocrine carcinoma of the cervix].

Qin JC, Li L, Yang ZJ, Yao DS, Li F, Zhang JQ.

Zhonghua Fu Chan Ke Za Zhi. 2011 May;46(5):360-3. Chinese.

PMID:
21733373
5.

Radical vaginal hysterectomy with extraperitoneal pelvic lymphadenectomy in cervical cancer.

Savino L, Borruto F, Comparetto C, Massi GB.

Eur J Gynaecol Oncol. 2001;22(1):31-5.

PMID:
11321490
6.

Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.

Liu MT, Hsu JC, Liu WS, Wang AY, Huang WT, Chang TH, Pi CP, Huang CY, Huang CC, Chou PH, Chen TH.

Eur J Cancer Care (Engl). 2008 Mar;17(2):174-81. doi: 10.1111/j.1365-2354.2007.00831.x.

PMID:
18302655
7.

Unfavorable prognosis of small cell neuroendocrine carcinoma of the uterine cervix: a retrospective matched case-control study.

Lee SW, Nam JH, Kim DY, Kim JH, Kim KR, Kim YM, Kim YT.

Int J Gynecol Cancer. 2010 Apr;20(3):411-6. doi: 10.1111/IGC.0b013e3181ce427b.

PMID:
20375806
8.

[Clinical study of 16 cases of villoglandular adenocarcinoma of uterine cervix].

Zhu X, Wu M, Tan X, Yu Q.

Zhonghua Yi Xue Za Zhi. 2015 Feb 17;95(7):519-22. Chinese.

PMID:
25916928
9.

Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer.

Angioli R, Plotti F, Montera R, Aloisi A, Luvero D, Capriglione S, Terranova C, De Cicco Nardone C, Muzii L, Benedetti-Panici P.

Gynecol Oncol. 2012 Nov;127(2):290-6. doi: 10.1016/j.ygyno.2012.07.104. Epub 2012 Jul 20.

PMID:
22819938
10.

Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.

Hiura M, Nogawa T, Matsumoto T, Yokoyama T, Shiroyama Y, Wroblewski J.

Int J Gynecol Cancer. 2010 Aug;20(6):1000-5. doi: 10.1111/IGC.0b013e3181d80aff.

PMID:
20683408
11.

Small cell neuroendocrine carcinoma of the cervix: analysis of the prognosis and role of radiation therapy for 43 cases.

Lan-Fang L, Hai-Yan S, Zuo-Ming Y, Jian-Qing Z, Ya-Qing C.

Eur J Gynaecol Oncol. 2012;33(1):68-73.

PMID:
22439409
12.

The outcome of laparoscopic radical hysterectomy and lymphadenectomy for cervical cancer: a prospective analysis of 295 patients.

Chen Y, Xu H, Li Y, Wang D, Li J, Yuan J, Liang Z.

Ann Surg Oncol. 2008 Oct;15(10):2847-55. doi: 10.1245/s10434-008-0063-3. Epub 2008 Jul 23.

PMID:
18649105
13.

Open versus laparoscopic pelvic lymph node dissection in early stage cervical cancer: no difference in surgical or disease outcome.

van de Lande J, von Mensdorff-Pouilly S, Lettinga RG, Piek JM, Verheijen RH.

Int J Gynecol Cancer. 2012 Jan;22(1):107-14. doi: 10.1097/IGC.0b013e31822c273d.

PMID:
21857347
14.

[Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].

Zhang WH, Wu LY, Bai P, Li SM, Zhang R, Li B, Sun JH, Wu AR.

Zhonghua Zhong Liu Za Zhi. 2004 Aug;26(8):490-2. Chinese.

PMID:
15555341
15.

Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.

Havrilesky LJ, Leath CA, Huh W, Calingaert B, Bentley RC, Soper JT, Alvarez Secord A.

Gynecol Oncol. 2004 May;93(2):429-34.

PMID:
15099957
16.

A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?

Rutledge TL, Kamelle SA, Tillmanns TD, Gould NS, Wright JD, Cohn DE, Herzog TJ, Rader JS, Gold MA, Johnson GA, Walker JL, Mannel RS, McMeekin DS.

Gynecol Oncol. 2004 Oct;95(1):70-6.

PMID:
15385112
17.

Is there a role for adjuvant hysterectomy after suboptimal concurrent chemoradiation in cervical carcinoma?

Walji N, Chue AL, Yap C, Rogers LJ, El-Modir A, Chan KK, Singh K, Fernando IN.

Clin Oncol (R Coll Radiol). 2010 Mar;22(2):140-6. doi: 10.1016/j.clon.2009.11.006. Epub 2010 Jan 4.

PMID:
20045300
20.

Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.

Ayhan A, Al RA, Baykal C, Demirtas E, Ayhan A, YĆ¼ce K.

Int J Gynecol Cancer. 2004 Mar-Apr;14(2):286-92.

PMID:
15086728

Supplemental Content

Support Center